196 related articles for article (PubMed ID: 25155258)
1. Mind the gap: models in multiple species needed for therapeutic development in Huntington's disease.
Howland DS; Munoz-Sanjuan I
Mov Disord; 2014 Sep; 29(11):1397-403. PubMed ID: 25155258
[TBL] [Abstract][Full Text] [Related]
2. Translating Antisense Technology into a Treatment for Huntington's Disease.
Lane RM; Smith A; Baumann T; Gleichmann M; Norris D; Bennett CF; Kordasiewicz H
Methods Mol Biol; 2018; 1780():497-523. PubMed ID: 29856033
[TBL] [Abstract][Full Text] [Related]
3. AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington's Disease Minipig Model.
Evers MM; Miniarikova J; Juhas S; Vallès A; Bohuslavova B; Juhasova J; Skalnikova HK; Vodicka P; Valekova I; Brouwers C; Blits B; Lubelski J; Kovarova H; Ellederova Z; van Deventer SJ; Petry H; Motlik J; Konstantinova P
Mol Ther; 2018 Sep; 26(9):2163-2177. PubMed ID: 30007561
[TBL] [Abstract][Full Text] [Related]
4. Genetic modifiers of Huntington's disease.
Gusella JF; MacDonald ME; Lee JM
Mov Disord; 2014 Sep; 29(11):1359-65. PubMed ID: 25154728
[TBL] [Abstract][Full Text] [Related]
5. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.
Wang LH; Qin ZH
Acta Pharmacol Sin; 2006 Oct; 27(10):1287-302. PubMed ID: 17007735
[TBL] [Abstract][Full Text] [Related]
6. [Huntington's disease: clinical and molecular genetics].
Warita H; Shiro Y; Kashihara K; Abe K
Nihon Rinsho; 1999 Apr; 57(4):896-9. PubMed ID: 10222786
[TBL] [Abstract][Full Text] [Related]
7. Weight loss in Huntington disease increases with higher CAG repeat number.
Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
[TBL] [Abstract][Full Text] [Related]
8. Nonhuman Primate Models of Huntington's Disease and Their Application in Translational Research.
Aron Badin R
Methods Mol Biol; 2018; 1780():267-284. PubMed ID: 29856024
[TBL] [Abstract][Full Text] [Related]
9. Viral-mediated overexpression of mutant huntingtin to model HD in various species.
Ruiz M; Déglon N
Neurobiol Dis; 2012 Nov; 48(2):202-11. PubMed ID: 21889981
[TBL] [Abstract][Full Text] [Related]
10. Huntington's disease: From molecular basis to therapeutic advances.
Krobitsch S; Kazantsev AG
Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115
[TBL] [Abstract][Full Text] [Related]
11. Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.
Miniarikova J; Evers MM; Konstantinova P
Mol Ther; 2018 Apr; 26(4):947-962. PubMed ID: 29503201
[TBL] [Abstract][Full Text] [Related]
12. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
13. [Huntington disease--yet another mad protein?].
Petersén A; Hansson O; Brundin P
Lakartidningen; 2001 Dec; 98(50):5756-8, 5761. PubMed ID: 11789098
[TBL] [Abstract][Full Text] [Related]
14. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.
Fink KD; Rossignol J; Crane AT; Davis KK; Bavar AM; Dekorver NW; Lowrance SA; Reilly MP; Sandstrom MI; von Hörsten S; Lescaudron L; Dunbar GL
Behav Neurosci; 2012 Jun; 126(3):479-87. PubMed ID: 22642889
[TBL] [Abstract][Full Text] [Related]
15. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
16. Huntington's disease.
Ha AD; Fung VS
Curr Opin Neurol; 2012 Aug; 25(4):491-8. PubMed ID: 22772878
[TBL] [Abstract][Full Text] [Related]
17. Experimental models of HD and reflection on therapeutic strategies.
Kim J; Bordiuk OL; Ferrante RJ
Int Rev Neurobiol; 2011; 98():419-81. PubMed ID: 21907096
[TBL] [Abstract][Full Text] [Related]
18. Huntington disease: pathogenesis and treatment.
Dayalu P; Albin RL
Neurol Clin; 2015 Feb; 33(1):101-14. PubMed ID: 25432725
[TBL] [Abstract][Full Text] [Related]
19. Huntington disease and the huntingtin protein.
Zheng Z; Diamond MI
Prog Mol Biol Transl Sci; 2012; 107():189-214. PubMed ID: 22482451
[TBL] [Abstract][Full Text] [Related]
20. Delivering a disease-modifying treatment for Huntington's disease.
Godinho BM; Malhotra M; O'Driscoll CM; Cryan JF
Drug Discov Today; 2015 Jan; 20(1):50-64. PubMed ID: 25256777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
